We examined the potential of several epithelial-derived factors to enhance
neutrophil activation and survival. Neutrophils incubated in the presence o
f supernatants from nasal-derived primary epithelial cultures had significa
ntly increased survival compared with neutrophils cultured in media alone.
Of the cytokines reported to enhance neutrophil survival, transcripts for i
nterleukin (LL)-1 alpha, 1L-1 beta, IL-6, and granulocyte macrophage colony
-stimulating factor (GM-CSF) (but not interferon-gamma or granulocyte colon
y-stimulating factor [G-CSF]) were detected by ribonuclease protection assa
y in basal and tumor necrosis factor (TNF)-alpha-stimulated epithelial cell
s. Of the eicosanoid products that enhance neutrophil survival, platelet-ac
tivating factor and leukotriene B-4 were not detected in the supernatants,
whereas prostaglandin E-2 (PGE(2)) was produced in modest amounts. The leve
ls of IL-6, GM-CSF, and PGE2 in epithelial supernatants were significantly
increased after transient TNF-alpha stimulation, This induction was suppres
sed if dexamethasone (Dex) was added during TNF-alpha stimulation. Only IL-
6, GM-CSF, and PGE(2) promoted neutrophil survival over the range of concen
trations detected in the supernatants, and a combination of neutralizing an
tibodies to GM-CSF and IL-6 completely inhibited the enhanced neutrophil su
rvival in epithelial supernatants. Both the terminal deoxynucleotidyl trans
ferase-mediated deoxyuridine triphosphate nick-end labeling technique and m
orphologic scoring of apoptotic neutrophils confirmed that epithelial super
natants, as well as purified IL-6, GM-CSF, and PGE(2) all delayed neutrophi
l apoptosis, Finally, the effects of Dex on neutrophil survival and on epit
helial cytokine production were investigated. Dex independently prolonged n
eutrophil survival but suppressed epithelial production of survival-enhanci
ng factors in a dose-dependent manner. The net effect of Dex appeared to fa
vor neutrophil survival.